These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 34360846)
1. Effects of Dihydrotanshinone I on Proliferation and Invasiveness of Paclitaxel-Resistant Anaplastic Thyroid Cancer Cells. Allegri L; Capriglione F; Maggisano V; Damante G; Baldan F Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360846 [TBL] [Abstract][Full Text] [Related]
2. Dihydrotanshinone exerts antitumor effects and improves the effects of cisplatin in anaplastic thyroid cancer cells. Allegri L; Domenis R; Navarra M; Celano M; Russo D; Capriglione F; Damante G; Baldan F Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34318905 [TBL] [Abstract][Full Text] [Related]
3. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer. Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531 [TBL] [Abstract][Full Text] [Related]
4. Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma. Milošević Z; Banković J; Dinić J; Tsimplouli C; Sereti E; Dragoj M; Paunović V; Milovanović Z; Stepanović M; Tanić N; Dimas K; Pešić M Cell Oncol (Dordr); 2018 Aug; 41(4):409-426. PubMed ID: 29790111 [TBL] [Abstract][Full Text] [Related]
5. INHIBITOR OF THE TRANSCRIPTION FACTOR NF-κB, DHMEQ, ENHANCES THE EFFECT OF PACLITAXEL ON CELLS OF ANAPLASTIC THYROID CARCINOMA IN VITRO AND IN VIVO. Pushkarev VV; Starenki DV; Pushkarev VM; Kovzun OI; Tronko MD Ukr Biochem J; 2015; 87(3):63-74. PubMed ID: 26502701 [TBL] [Abstract][Full Text] [Related]
6. Combination of SL327 and Sunitinib Malate leads to an additive anti-cancer effect in doxorubicin resistant thyroid carcinoma cells. Wang W; Zhou J; Zhao L; Chen S Biomed Pharmacother; 2017 Apr; 88():985-990. PubMed ID: 28178630 [TBL] [Abstract][Full Text] [Related]
7. Synergistic anticancer activity of sorafenib, paclitaxel, and radiation therapy on anaplastic thyroid cancer in vitro and in vivo. Kim SY; Kim SM; Chang H; Chang HS; Park CS; Lee YS Head Neck; 2020 Dec; 42(12):3678-3684. PubMed ID: 32896015 [TBL] [Abstract][Full Text] [Related]
8. GSK2801 Reverses Paclitaxel Resistance in Anaplastic Thyroid Cancer Cell Lines through MYCN Downregulation. Molteni E; Baldan F; Damante G; Allegri L Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983070 [TBL] [Abstract][Full Text] [Related]
9. Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells. Allegri L; Baldan F; Mio C; Puppin C; Russo D; Kryštof V; Damante G Oncol Rep; 2016 Apr; 35(4):2413-8. PubMed ID: 26884249 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells. Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ Tumour Biol; 2017 May; 39(5):1010428317698369. PubMed ID: 28459364 [TBL] [Abstract][Full Text] [Related]
11. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma. Wang Z; Qiu X; Zhang H; Li W J Biochem Mol Toxicol; 2020 May; 34(5):e22469. PubMed ID: 32173973 [TBL] [Abstract][Full Text] [Related]
12. Non‑invasive monitoring of paclitaxel and lenvatinib efficacy against anaplastic thyroid cancer in orthotopic SCID mouse models using small‑animal FDG‑PET/CT. Aoyama M; Takizawa H; Otani T; Inoue S; Kawakita N; Tsuboi M; Bando Y; Uehara H; Kondo K; Tangoku A Oncol Rep; 2020 Oct; 44(4):1709-1716. PubMed ID: 32945510 [TBL] [Abstract][Full Text] [Related]
13. Potent antitumor activity of novel taxoids in anaplastic thyroid cancer. Wang M; Wang C; Feng C; Guo W; Chen H; Liu B; Li E; Liu W; Taouil A; Ojima I; Hou P Endocrine; 2022 Feb; 75(2):465-477. PubMed ID: 34591230 [TBL] [Abstract][Full Text] [Related]
14. Effects of nutraceuticals on anaplastic thyroid cancer cells. Allegri L; Rosignolo F; Mio C; Filetti S; Baldan F; Damante G J Cancer Res Clin Oncol; 2018 Feb; 144(2):285-294. PubMed ID: 29197967 [TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA (siRNA) against Slug induces apoptosis and sensitizes human anaplastic thyroid carcinoma cells to doxorubicin. Pan Y; Liu P; Chen D; Dou L Cancer Biomark; 2017; 18(4):357-366. PubMed ID: 28128736 [TBL] [Abstract][Full Text] [Related]
16. Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo. Ferrari SM; Bocci G; Di Desidero T; Elia G; Ruffilli I; Ragusa F; Orlandi P; Paparo SR; Patrizio A; Piaggi S; La Motta C; Ulisse S; Baldini E; Materazzi G; Miccoli P; Antonelli A; Fallahi P Oncol Rep; 2018 May; 39(5):2225-2234. PubMed ID: 29517103 [TBL] [Abstract][Full Text] [Related]
17. miR-27b-3p is Involved in Doxorubicin Resistance of Human Anaplastic Thyroid Cancer Cells via Targeting Peroxisome Proliferator-Activated Receptor Gamma. Xu Y; Han YF; Ye B; Zhang YL; Dong JD; Zhu SJ; Chen J Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):670-677. PubMed ID: 29924913 [TBL] [Abstract][Full Text] [Related]
18. Dihydrotanshinone I exhibits antitumor effects via β-catenin downregulation in papillary thyroid cancer cell lines. Molteni E; Baldan F; Damante G; Allegri L Sci Rep; 2024 Apr; 14(1):7853. PubMed ID: 38570592 [TBL] [Abstract][Full Text] [Related]
19. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis. Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839 [TBL] [Abstract][Full Text] [Related]
20. Effects of melatonin on the toxicity and proliferation of human anaplastic thyroid cancer cell line. Ghorbani-Anarkooli M; Dabirian S; Zendedel A; Moladoust H; Bahadori MH Acta Histochem; 2021 Apr; 123(3):151700. PubMed ID: 33667778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]